Actinium Pharmaceuticals Inc. (Delaware)

(ATNM)

By |

Profile

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's product portfolio includes Iomab-B and Actimab-A.

Contact Information

Website: www.actiniumpharma.com
Email: investorrelations@actiniumpharma.com
Main Phone: +1 646 677-3870
Address: 275 Madison Avenue
Address 2: 7th Floor
State: NY
City / Town: New York
Country: USA
Postal Code: 10016

Issuer Information

Exchange: AMX
CEO: Sandesh Seth
Employees: 25
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 0.68 $ 0.10 (17.57%)
Last Price 0.68 Change $ 0.10 Change % 17.57 Tick N/A
Bid 0.68 Bid Size 200.00 Ask 0.68 Ask Size 2,500.00
Open 0.61 High 0.74 Low 0.58 Prev Close 0.58
Last Trade Volume 5.2 mi 52 Wk Hi 1.33 52 Wk Low 0.33
Market Cap 75.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 110,317,228.00 EPS (TTM) -0.34 PE Ratio N/A Exchange NYSE American
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 9
Number of Buys 1 9
Number of Sells 0 0
Net Activity 5000 164563
Last 10 Buys Shares
Sandesh Seth 1,000
Ajit S. Shetty 1,000
Sandesh Seth 1,000
Nitya G. Ray 1,000
Sandesh Seth 1,000
Sandesh Seth 1,000
Steven O'Loughlin 1,000
Mark S. Berger 1,000
Sandesh Seth 1,000
Sandesh Seth 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 6 6 6 8
Low Target Price Estimate 2.75 2.75 2.75 2.75
Mean Target Price Estimate 4.19 4.19 3.92 4.95
Standard Deviation 1.57 1.57 1.81 2.18
Date of Most Recent Estimate 05/31/18 05/29/18 05/23/18 05/31/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 4 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1